Group 1 - The company Dongcheng Pharmaceutical (002675) announced on August 18 that it will prioritize the outsourcing of its diagnostic product, Lanacheng, to Andico for production and sales [1] - Andico is also required to ensure the product demand for Lanacheng is met [1] - The cooperation model for therapeutic nuclear medicine products has not yet been determined [1]